CIRCHE — CirChem AB Balance Sheet
0.000.00%
- SEK41.21m
- SEK40.46m
- SEK9.96m
Annual balance sheet for CirChem AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 14.6 | 9.78 | 16.6 | 11.9 | 13.6 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.693 | 0.583 | 1.87 | 1.94 | 2.35 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 16.2 | 10.6 | 18.7 | 14.4 | 17 |
| Net Property, Plant And Equipment | 36 | 39.7 | 40.4 | 46.7 | 52.5 |
| Other Long Term Assets | |||||
| Total Assets | 52.1 | 50.3 | 59.1 | 61.2 | 69.5 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 23 | 23.4 | 15.1 | 10 | 12.2 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 25.8 | 25.2 | 24 | 15.5 | 25.1 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 26.4 | 25.1 | 35.1 | 45.7 | 44.3 |
| Total Liabilities & Shareholders' Equity | 52.1 | 50.3 | 59.1 | 61.2 | 69.5 |
| Total Common Shares Outstanding |